DV
Dividend Vision

ENTX — Entera Bio Ltd

Entera Bio Ltd (ENTX)

Total return is -54.0% over the past 8.1 years, 277.7 points behind SPY at 223.7%. Its deepest 1-year drawdown was 68.2%.

ENTX is an equity stock focused on biotech and life sciences exposure. The fund does not currently offer dividend distributions, making it unsuitable for income-focused investors seeking regular payouts. This holding appeals primarily to growth-oriented investors interested in the biotechnology sector rather than those prioritizing dividend yield.

ENTX key facts

Asset type
Stock
Asset class
Equity
Inception date
06/28/2018
Last close
$2.89
Market cap
$97,594,664
Average volume
278331.0
Beta
1.433
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.26